Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Leflunomide preclinical results presented at transplant congress

June 2, 1997

BTI-322 preclinical and clinical data disclosed at transplant meeting

June 2, 1997

Merck & Co. discloses pneumococcal vaccines

June 2, 1997

Protein Sciences' influenza vaccine covered under U.S. patent

June 2, 1997

Pasteur Merieux Connaught launches combination vaccine with acellular component

May 29, 1997

Losartan effective in chronic renal allograft rejection

May 28, 1997

MC-1288 + ciclosporin for allograft rejection

May 26, 1997

Highlights of the 7th INWIN

May 26, 1997

North American Vaccine cleared to initiate trials of meningitis vaccine

May 22, 1997

Malononitrilamides associated with potent immunosuppressive effects in animal models

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...